Abstract:Objective To explore ability of the vpr gene of human immunodeficiency virus type 1 ( HIV-1 vpr) to induce cell G_2 arrest and apoptosis, and the influence when it mutated, the relationship between Vpr-induced G_2 arrest and apoptosis inductions. Methods Fourteen mutant vpr fragments selected from Chinese patients with HIV. Both eukaryotic expression vector pcDNA3.1( + ) and PCR products purified, double-cut by Hind Ⅲ and BamH Ⅰ and the cut products legated and transformed into competent cells JM109. The 14 reconstructed plasmids electronically transfected into Jurkat-cells, and established cells with pcDNA3. 1-vpr , pcDNA3. 1-vpr-Fs and pcDNA3. 1 blank cells, and without pcDNA3. 1 cell. Cells were harvested after 24 h. mRNA expression was detected by RT-PCR, the DNA content and percentage of apoptosis were monitored by flow cytometry. Results Transfected with 14 mutant HIV-1 Vpr protein, cells display different G_2 percentage and apoptosis ratio. HIV-1 vpr induce cell cycle G_2 arrest and apoptosis, wherase Vpr Fs with a C-terminal end truncation, vector pcDNA3.1( + ) and the blank cells can not. The G_2 percentage and apoptosis ratio reduced when transfected with vpr expressing mutating of 70V, 85P, 86G, 94G compared to the wild type. Subtype AE has a weaker potential to induce cell cycle G_2 arrest and apoptosis. Preliminary, we find that the higher G_2 percentage followed the higher ratio of apoptosis. Conclusion HIV-1 vpr can induce cell cycle G_2 arrest and apoptosis, wherase Vpr Fs with a C-terminal end truncation can not. We firstly found that mutated sites of 70V, 85P, 86G, 94G may reduce the ability of Vpr to induce cell cycle G_2 arrest and apoptosis, subtype AE of vpr in Chinese HIV-1 patients has a weaker potential to induce cell cycle G_2 arrest and apoptosis. Analysis of various mutations in the vpr gene revealed that the extent of Vpr-induced G_2 arrest correlated with the levels of apoptosis. And investigate the pathegenesis of HIV vpr. This can also make a good foundation for further study on gene therapy.

HIV-1 Vpr Protein Upregulates Microrna-210-5p Expression to Induce G2 Arrest by Targeting TGIF2

HIV-1 Vpr Protein Activates the NF-κB Pathway to Promote G2/M Cell Cycle Arrest

Identify Potential Regulators in Hiv-1 Latency by Joint Microrna and Mrna Analysis

The Hiv-1 Vif Protein Mediates Degradation Of Vpr And Reduces Vpr-Induced Cell Cycle Arrest

HIV Vpr protein up-regulates microRNA-122 expression and stimulates hepatitis C virus replication.

HIV-1 Vpr causes separate cell cycle arrests in G2 and M that activate alternative DNA damage pathways

HIV-1 Vpr suppresses the cytomegalovirus promoter in a CRL4(DCAF1) E3 ligase independent manner.

HIV-1 Vpr Induces Interferon-Stimulated Genes in Human Monocyte-Derived Macrophages

Genetic Variance in the HIV-1 Founder Virus Vpr Affects Its Ability to Induce Cell Cycle G₂arrest and Cell Apoptosis.

Vpr Targets TET2 for Degradation by CRL4VprBP E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication

HIV-1 Vpr Degrades TET2 to Suppress IRF7 and Interferon Expression in Plasmacytoid Dendritic Cells

High-throughput Sequencing Identifies HIV-1-replication- and Latency-Related Mirnas in CD4+ T Cell Lines.

Effect of HIV-1 Vpr on G2 arrest and apoptosis in Hela cell

Study on Effects of G_2 Arrest and Apoptosis in Jurkat Cell by HTV-1 Vpr

Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages

Vpr driving DNA methylation variation of CD4 + T cells in HIV-1 infection

Effect of RelB on HIV-1 Vpr-mediated Transcription Activation and Cell G2/MArrest

HIV-1 Vpr Activates Both Canonical and Noncanonical NF-κB Pathway by Enhancing the Phosphorylation of IKKα/β.

Interaction of Virion Protein Vpr of Human Immunodeficiency Virus Type 1 with Cellular Transcription Factor Sp1 and trans-Activation of Viral Long Terminal Repeat

HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages

The study of the expressions of apoptosis and its related protein by knockdown of human immunodeficiency virus-1 vpr gene